aposense Aposense Ltd. is a Molecular Imaging and Drug Development Company, focusing on the introduction of novel agents based on the identification and targeting of cells undergoing apoptosis (programmed cell death). Aposense has developed a set of proprietary compounds with demonstrated ability to identify, bind and accumulate within apoptotic (dying) cells in-vivo.